273 related articles for article (PubMed ID: 7774675)
1. Characterisation of melanocortin receptor subtypes by radioligand binding analysis.
Schiöth HB; Muceniece R; Wikberg JE; Chhajlani V
Eur J Pharmacol; 1995 Feb; 288(3):311-7. PubMed ID: 7774675
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of the melanocortin 4 receptor by radioligand binding.
Schiöth HB; Muceniece R; Wikberg JE
Pharmacol Toxicol; 1996 Sep; 79(3):161-5. PubMed ID: 8884876
[TBL] [Abstract][Full Text] [Related]
3. Cyclic lactam alpha-melanotropin analogues of Ac-Nle4-cyclo[Asp5, D-Phe7,Lys10] alpha-melanocyte-stimulating hormone-(4-10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors.
Hruby VJ; Lu D; Sharma SD; Castrucci AL; Kesterson RA; al-Obeidi FA; Hadley ME; Cone RD
J Med Chem; 1995 Sep; 38(18):3454-61. PubMed ID: 7658432
[TBL] [Abstract][Full Text] [Related]
4. Characterization of melanocortin receptor ligands on cloned brain melanocortin receptors and on grooming behavior in the rat.
Adan RA; Szklarczyk AW; Oosterom J; Brakkee JH; Nijenhuis WA; Schaaper WM; Meloen RH; Gispen WH
Eur J Pharmacol; 1999 Aug; 378(3):249-58. PubMed ID: 10493100
[TBL] [Abstract][Full Text] [Related]
5. The melanocortin 1, 3, 4 or 5 receptors do not have a binding epitope for ACTH beyond the sequence of alpha-MSH.
Schiöth HB; Muceniece R; Larsson M; Wikberg JE
J Endocrinol; 1997 Oct; 155(1):73-8. PubMed ID: 9390008
[TBL] [Abstract][Full Text] [Related]
6. Molecular cloning of a mouse melanocortin 5 receptor gene widely expressed in peripheral tissues.
Labbé O; Desarnaud F; Eggerickx D; Vassart G; Parmentier M
Biochemistry; 1994 Apr; 33(15):4543-9. PubMed ID: 8161509
[TBL] [Abstract][Full Text] [Related]
7. Interaction of melanin-concentrating hormone (MCH), neuropeptide E-I (NEI), neuropeptide G-E (NGE), and alpha-MSH with melanocortin and MCH receptors on mouse B16 melanoma cells.
Hintermann E; Tanner H; Talke-Messerer C; Schlumberger S; Zumsteg U; Eberle AN
J Recept Signal Transduct Res; 2001 Feb; 21(1):93-116. PubMed ID: 11693176
[TBL] [Abstract][Full Text] [Related]
8. Identification of antagonists for melanocortin MC3, MC4 and MC5 receptors.
Adan RA; Oosterom J; Ludvigsdottir G; Brakkee JH; Burbach JP; Gispen WH
Eur J Pharmacol; 1994 Nov; 269(3):331-7. PubMed ID: 7895772
[TBL] [Abstract][Full Text] [Related]
9. Investigation of the melanocyte stimulating hormones on food intake. Lack Of evidence to support a role for the melanocortin-3-receptor.
Abbott CR; Rossi M; Kim M; AlAhmed SH; Taylor GM; Ghatei MA; Smith DM; Bloom SR
Brain Res; 2000 Jun; 869(1-2):203-10. PubMed ID: 10865075
[TBL] [Abstract][Full Text] [Related]
10. Major pharmacological distinction of the ACTH receptor from other melanocortin receptors.
Schiöth HB; Chhajlani V; Muceniece R; Klusa V; Wikberg JE
Life Sci; 1996; 59(10):797-801. PubMed ID: 8761313
[TBL] [Abstract][Full Text] [Related]
11. [Detection of binding activity and biologic effect of a novel alpha-melanocyte-stimulating hormone analogue].
Ying Y; Lan XP; Tian YP
Yao Xue Xue Bao; 2007 Mar; 42(3):269-73. PubMed ID: 17520825
[TBL] [Abstract][Full Text] [Related]
12. Selective properties of C- and N-terminals and core residues of the melanocyte-stimulating hormone on binding to the human melanocortin receptor subtypes.
Schiöth HB; Mutulis F; Muceniece R; Prusis P; Wikberg JE
Eur J Pharmacol; 1998 May; 349(2-3):359-66. PubMed ID: 9671118
[TBL] [Abstract][Full Text] [Related]
13. Molecular cloning, functional expression and pharmacological characterization of a mouse melanocortin receptor gene.
Desarnaud F; Labbe O; Eggerickx D; Vassart G; Parmentier M
Biochem J; 1994 Apr; 299 ( Pt 2)(Pt 2):367-73. PubMed ID: 8172596
[TBL] [Abstract][Full Text] [Related]
14. Selectivity of cyclic [D-Nal7] and [D-Phe7] substituted MSH analogues for the melanocortin receptor subtypes.
Schiöth HB; Müceniece R; Mutulis F; Prusis P; Lindeberg G; Sharma SD; Hruby VJ; Wikberg JE
Peptides; 1997; 18(7):1009-13. PubMed ID: 9357059
[TBL] [Abstract][Full Text] [Related]
15. Binding of cyclic and linear MSH core peptides to the melanocortin receptor subtypes.
Schiöth HB; Muceniece R; Larsson M; Mutulis F; Szardenings M; Prusis P; Lindeberg G; Wikberg JE
Eur J Pharmacol; 1997 Jan; 319(2-3):369-73. PubMed ID: 9042613
[TBL] [Abstract][Full Text] [Related]
16. Binding and biological activity of C-terminally modified melanocortin peptides: a comparison between their actions at rodent MC1 and MC3 receptors.
Peng PJ; Sahm UG; Doherty RV; Kinsman RG; Moss SH; Pouton CW
Peptides; 1997; 18(7):1001-8. PubMed ID: 9357058
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the binding of MSH-B, HB-228, GHRP-6 and 153N-6 to the human melanocortin receptor subtypes.
Schiöth HB; Muceniece R; Wikberg JE
Neuropeptides; 1997 Dec; 31(6):565-71. PubMed ID: 9574823
[TBL] [Abstract][Full Text] [Related]
18. Characterization of melanocortin receptor subtype expression in murine adipose tissues and in the 3T3-L1 cell line.
Boston BA; Cone RD
Endocrinology; 1996 May; 137(5):2043-50. PubMed ID: 8612546
[TBL] [Abstract][Full Text] [Related]
19. Subtype selective binding properties of substituted linear melanocyte stimulating hormone analogues.
Schiöth HB; Tesfaye A; Mutulis F; Rudzish R; Mutule I; Muceniece R; Watanobe H; Wikberg JE
Neuropeptides; 2002 Dec; 36(6):427-34. PubMed ID: 12507437
[TBL] [Abstract][Full Text] [Related]
20. Selectivity of [Phe-I7], [Ala6], and [D-Ala4,Gln5,Tyr6] substituted ACTH(4-10) analogues for the melanocortin receptors.
Schiöth HB; Muceniece R; Wikberg JE
Peptides; 1997; 18(5):761-3. PubMed ID: 9213373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
